A tool to help local commissioners provide cost-effective interventions for the prevention and treatment of musculoskeletal conditions. Continue reading
A standard set of indicators for musculoskeletal health services relevant to people with arthritis and commissioners, created in partnership with the musculoskeletal community. The indicators describe the value, quality and cost of musculoskeletal services, aimed at those who are responsible for shaping services (commissioners and providers) and also relevant and meaningful to clinicians and patients. Continue reading
Arthritis Research UK has partnered with Imperial College London to develop the Musculoskeletal Calculator, a tool designed to produce prevalence estimates (i.e. how many people have a condition) for musculoskeletal (MSK) conditions. Estimates are currrently available for osteoarthritis (OA) of the hip and knee, back pain and rheumatoid arthritis (RA) for England and Scotland. Continue reading
The State of Musculoskeletal Health 2018 is a resource for health professionals, policy makers, public health leads and anyone interested in musculoskeletal health.
The document contains the best available data on the prevalence, risk factors, comorbidities, and impact of musculoskeletal conditions in the UK, so you can understand more about the number of people living with and affected by these conditions.
Quality Standards for Osteoporosis and Prevention of Fragility Fractures
Identifying vertebral fractures systematically has proven challenging for all clinicians and currently more than two-thirds are undiagnosed. The purpose of this guidance is to ensure that all vertebral fractures are systematically identified, reported using clear terminology to the referring clinician and lead to appropriate management to avoid further fragility fractures.
Clinical Guidance for the Effective Identification of Vertebral Fractures
Derived from current guidance, these seven standards reflect high-quality practice across the fracture prevention pathway. Detailed criteria and measures are included to allow evaluation of service performance. They provide the foundation for Peer Review of osteoporosis services.
Bisphosphonates in primary care: starting, reviewing and stopping
In this interactive webinar, the GP and rheumatologist presenters, acknowledging the multiplicity of guidance on osteoporosis management, present a pragmatic approach to risk assessment, treatment initiation, patient reviews, and drug ‘holidays’ or cessation. A reference flowchart and potential targets for audit is also provided.
Gain CPD accreditation by completing theRoyal College of General Practitioners (RCGP) and National Osteoporosis Society’s e-learning osteoporosis module. This half-hour e-learning module will test your knowledge of osteoporosis management including:
– identifying high risk patients
– when to initiate treatment
– how often to monitor patients
This e-Learning course will give you an understanding of osteoporosis, its assessment and prevention with specific relevance to the principles and practical techniques of DXA.
The modules are free to access and will take around 4 hours to complete. The assessment is CPD accredited and costs £50.00.